Medicine & Life Sciences
Mantle-Cell Lymphoma
100%
Agammaglobulinaemia Tyrosine Kinase
54%
PCI 32765
45%
Antineoplastic Agents
19%
p31 integrase protein, Human immunodeficiency virus 1
17%
pyrrolopyrimidine
16%
HIV Integrase Inhibitors
14%
Neoplasms
12%
Cell Line
11%
Chimeric Antigen Receptors
10%
Pyrrolo(2,3-d)pyrimidine
9%
indole
9%
Apoptosis
9%
5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide
9%
Therapeutics
8%
indoline-2,3-dione
8%
8-aza-7-deazaadenine
8%
Phosphatidylinositol 3-Kinases
8%
indole-2-carboxylate
8%
Rituximab
8%
zanubrutinib
8%
indolin-2-one
7%
Oxadiazoles
7%
PC-3 Cells
6%
Thiadiazoles
6%
salicylamide
6%
CUDC-907
6%
Heterografts
6%
Cyclin-Dependent Kinase 9
6%
Pyrimidinones
6%
Isatin
6%
venetoclax
6%
Prostatic Neoplasms
5%
B-Lymphocytes
5%
Protein-Arginine N-Methyltransferases
5%
Androgen Receptor Antagonists
5%
B-Cell Lymphoma
5%
Integrase Inhibitors
5%
prednylidene
5%
pyrazole
5%
Thioredoxin-Disulfide Reductase
5%
Phosphorylation
5%
Lead
5%
Inhibitor of Apoptosis Proteins
5%
Pharmaceutical Chemistry
5%
Quantitative Structure-Activity Relationship
5%
Immunoconjugates
5%
Chemistry
Tyrosine Kinase Inhibitor
36%
Ibrutinib
30%
Antiproliferative
27%
Tyrosine
20%
Pyrrolopyrimidine
18%
Antineoplastic Agent
13%
HIV-1 Integrase Inhibitor
11%
Pyrimidine
9%
Dose
7%
Indole
7%
Pyrimidin-4-Amine
6%
Integrase Inhibitor
5%
Pyrazolopyrimidine
5%
Pyrimidone
5%
Addition Compound
5%
Salicylamide
5%
Indolin-2-One
5%
Thiadiazoles
5%